NYSE:PRAProAssurance Stock Price, Forecast & News

ProAssurance's stock was trading at $21.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRA shares have decreased by 29.0% and is now trading at $15.15.
View which stocks have been most impacted by COVID-19.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProAssurance in the last year. There are currently 2 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for ProAssurance.

ProAssurance is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for ProAssurance.

ProAssurance Co. (NYSE:PRA) announced its quarterly earnings data on Monday, August, 10th. The insurance provider reported ($0.60) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.67) by $0.07. The insurance provider earned $221.74 million during the quarter, compared to analyst estimates of $231.76 million. ProAssurance had a negative net margin of 5.67% and a negative return on equity of 3.21%. The business's quarterly revenue was down 7.5% compared to the same quarter last year. During the same period last year, the firm earned $0.08 EPS.
View ProAssurance's earnings history.

ProAssurance announced a quarterly dividend on Thursday, May 7th. Stockholders of record on Thursday, June 11th will be given a dividend of $0.05 per share on Wednesday, July 8th. This represents a $0.20 annualized dividend and a dividend yield of 1.32%. The ex-dividend date is Wednesday, June 10th.
View ProAssurance's dividend history.

6 equities research analysts have issued 12 month price objectives for ProAssurance's shares. Their forecasts range from $14.00 to $36.00. On average, they expect ProAssurance's share price to reach $25.25 in the next twelve months. This suggests a possible upside of 66.7% from the stock's current price.
View analysts' price targets for ProAssurance.

Media headlines about PRA stock have trended neutral on Saturday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ProAssurance earned a news sentiment score of 0.0 on InfoTrie's scale. They also assigned press coverage about the insurance provider a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about ProAssurance.

ProAssurance saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 791,600 shares, a decline of 37.2% from the May 31st total of 1,260,000 shares. Based on an average daily volume of 504,500 shares, the days-to-cover ratio is currently 1.6 days. Currently, 1.5% of the company's stock are short sold.
View ProAssurance's Short Interest.

Some companies that are related to ProAssurance include Berkshire Hathaway (BRK.B), Progressive (PGR), Travelers Companies (TRV), Allstate (ALL), Markel (MKL), Cincinnati Financial (CINF), Arch Capital Group (ACGL), W. R. Berkley (WRB), Fidelity National Financial (FNF), Erie Indemnity (ERIE), Cna Financial (CNA), First American Financial (FAF), Old Republic International (ORI), RLI (RLI) and Hanover Insurance Group (THG).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ProAssurance investors own include AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Uniti Group (UNIT), Walgreens Boots Alliance (WBA), Consolidated Edison (ED), Energy Transfer LP Unit (ET), General Electric (GE), General Mills (GIS) and KeyCorp (KEY).

ProAssurance trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRA."

ProAssurance's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.92%), Diamond Hill Capital Management Inc. (4.27%), Bank of New York Mellon Corp (1.40%), Federated Hermes Inc. (0.94%), Principal Financial Group Inc. (0.75%) and Mesirow Financial Investment Management Equity Management (0.67%). Company insiders that own ProAssurance stock include Frank Anthony Spinosa and John J Mcmahon, Jr.
View institutional ownership trends for ProAssurance.

PRA stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Vanguard Group Inc., Bank of America Corp DE, Bank of New York Mellon Corp, Russell Investments Group Ltd., Nisa Investment Advisors LLC, Prudential Financial Inc., and New York State Common Retirement Fund.
View insider buying and selling activity for ProAssurance.

PRA stock was bought by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Federated Hermes Inc., Mesirow Financial Investment Management Equity Management, Assenagon Asset Management S.A., Smith Graham & Co. Investment Advisors LP, Cubist Systematic Strategies LLC, Marshall Wace LLP, and Aigen Investment Management LP.
View insider buying and selling activity for ProAssurance.

Shares of PRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRA stock can currently be purchased for approximately $15.15.

ProAssurance has a market capitalization of $816.42 million and generates $999.83 million in revenue each year. The insurance provider earns $1 million in net income (profit) each year or ($0.81) on an earnings per share basis. ProAssurance employs 991 workers across the globe.

The official website for ProAssurance is www.proassurance.com.

ProAssurance's mailing address is 100 Brookwood Place, Birmingham AL, 35209. The insurance provider can be reached via phone at 205-877-4400 or via email at [email protected]